Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health (INTEGRATE-CHW)
Integrating Tailored Medical Nutrition Therapy and Community Health Worker Support to Advance Cardio-Kidney-Metabolic Health
This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit.
Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.
Studie Overzicht
Toestand
Toestand
Conditie
Conditie
Interventie / Behandeling
Interventie / Behandeling
Gedetailleerde beschrijving
Dietitian-led MNT and medically tailored food programs improve diet quality and food security during active participation, but these gains often diminish once food delivery or counseling ends. Sustaining improvement requires ongoing behavioral reinforcement and self-management support that help patients adapt nutrition guidance to their cultural and household routines. This trial tests whether CHWs embedded in the dietitian's workflow can provide that reinforcement within routine care at a safety-net clinic.
The intervention is guided by Social Cognitive Theory, the Corbin and Strauss self-management framework, and Lorig and Holman's self-management skills. Self-efficacy serves as the central behavioral mechanism of change, operationalized through confidence-based goal setting, problem solving, and action planning. Enhanced self-efficacy is expected to improve adherence to dietary goals and, in turn, clinical cardio-kidney-metabolic indicators.
Aim 1 will determine the effect of INTEGRATE-CHW on behavioral outcomes. Aim 2 will examine preliminary effects on clinical outcomes. Aim 3 will evaluate implementation using mixed methods guided by RE-AIM and Proctor's framework, including semi-structured interviews with approximately 15 intervention participants and 5 staff (CHWs, registered dietitians, and clinic leads) exploring satisfaction, perceived burden, and workflow fit.
Analyses follow the intent-to-treat principle with two-sided tests (α = 0.05) and Benjamini-Hochberg false-discovery control. Between-group differences at Week 12 are estimated with analysis of covariance adjusting for baseline values. Behavioral models adjust for age, sex, language, baseline food insecurity, and CKD status. Clinical models adjust for age, sex, CKM profile, and medication classes (SGLT2 inhibitor, GLP-1 receptor agonist, ACE inhibitor/ARB, and statin use). Linear mixed-effects models are used for sensitivity analyses. Exploratory analyses test effect modification by baseline food insecurity, nutrition literacy level, and dominant CKM condition, and test whether changes in self-efficacy, literacy, or diet quality mediate changes in clinical indicators. A total of 200 participants (100 per arm) provides at least 80% power (α = 0.05) to detect a small-to-moderate effect (Cohen's d ≈ 0.35).
Studietype
Studietype
Inschrijving (Geschat)
Inschrijving
Fase
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
Studiecontact
- Naam: Jordan Program coordinator
- Telefoonnummer: 305-348-4720
- E-mail: joquinta@fiu.edu
Studie Locaties
-
-
Florida
-
Boynton Beach, Florida, Verenigde Staten, 33472
- Caridad Center, Inc.
-
-
Deelname Criteria
Geschiktheidscriteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Adults aged 18 years or older receiving care at Caridad Center
- Documented diagnosis of type 2 diabetes (HbA1c ≥ 6.5%), hypertension (systolic blood pressure ≥ 130 mmHg), or chronic kidney disease Stages 1-4 (eGFR 15-59 mL/min/1.73 m² regardless of albuminuria, or eGFR ≥ 15 mL/min/1.73 m² with albuminuria ≥ 30 mg/g)
- Eligible for medical nutrition therapy and medically tailored groceries through -Caridad Center
- Able to provide informed consent in English or Spanish
Exclusion Criteria:
- Dialysis or advanced kidney failure (CKD Stage 5; eGFR < 15 mL/min/1.73 m²)
- Pregnancy
- Cognitive impairment precluding participation
- Plans to relocate during the 12-week intervention
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Aantal wapens
Wapens en interventies
Deelnemersgroep / ArmDeelnemersgroep / Arm |
Interventie / BehandelingInterventie / Behandeling |
|---|---|
|
Experimenteel: INTEGRATE-CHW
Usual care plus a 12-week CHW-delivered, nutrition-focused self-management support program: six sessions of approximately 60 minutes at Weeks 1, 3, 5, 7, 9, and 11, delivered in person or virtually by participant preference, and a Week 12 wrap-up aligned with the routine dietitian visit and laboratory review. |
Trained CHWs deliver culturally tailored sessions using FlipChart visuals, pictorial goal cards, and recipe swaps. The curriculum covers diet and CKM links and home blood pressure and glucose monitoring (Session 1), diabetes (Session 2), hypertension (Session 3), CKD (Session 4), cardiometabolic integration (Session 5), and maintenance (Session 6). Participants select one to two goals from their dietitian's plan and build confidence-rated action plans. CHWs reinforce, but do not modify, dietitian guidance. Between sessions, CHWs provide reminder and follow-up contact by telephone or text message. Participants enter home blood pressure and glucose readings and goals into REDCap directly or with CHW assistance. |
|
Actieve vergelijker: Usual Care
Caridad Center standard care: individualized medical nutrition therapy from a registered dietitian approximately every three months and medically tailored groceries or meal boxes biweekly for 12 weeks. |
Individualized medical nutrition therapy from a registered dietitian following the Academy of Nutrition and Dietetics' Nutrition Care Process, plus biweekly medically tailored groceries or meal boxes for 12 weeks. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change From Baseline in Nutrition Self-Efficacy Scale Score at Week 12
Tijdsspanne: Baseline and Week 12
|
5-item Nutrition Self-Efficacy Scale, which measures confidence in maintaining healthy eating behaviors despite common barriers. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Short Food Literacy Questionnaire (SFLQ) Score at Week 12
Tijdsspanne: Baseline and Week 12
|
12-item Short Food Literacy Questionnaire (SFLQ), which evaluates the ability to interpret nutrition information, read labels, and make balanced food choices. Interviewer-administered in English or Spanish. |
Baseline and Week 12
|
|
Change From Baseline in Healthy Eating Index-2020 (HEI-2020) Total Score at Week 12
Tijdsspanne: Baseline and Week 12
|
Healthy Eating Index-2020 (HEI-2020) total score, derived from two 24-hour dietary recalls. |
Baseline and Week 12
|
Secundaire uitkomstmaten
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change From Baseline in USDA Six-Item Food Security Module Score at Week 12
Tijdsspanne: Baseline and Week 12
|
USDA six-item food security module. |
Baseline and Week 12
|
|
Change From Baseline in HbA1c (%) at Week 12
Tijdsspanne: Baseline and Week 12
|
Glycated hemoglobin (%), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Systolic Blood Pressure (mmHg) at Week 12
Tijdsspanne: Baseline and Week 12
|
Systolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Diastolic Blood Pressure (mmHg) at Week 12
Tijdsspanne: Baseline and Week 12
|
Diastolic blood pressure (mmHg), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Body Mass Index (kg/m²) at Week 12
Tijdsspanne: Baseline and Week 12
|
Body mass index (kg/m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Lipid Profile at Week 12
Tijdsspanne: Baseline and Week 12
|
Lipid profile, extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in eGFR (mL/min/1.73 m²) at Week 12
Tijdsspanne: Baseline and Week 12
|
eGFR (mL/min/1.73 m²), extracted from the electronic medical record. |
Baseline and Week 12
|
|
Change From Baseline in Urinary Albumin-to-Creatinine Ratio (mg/g) at Week 12
Tijdsspanne: Baseline and Week 12
|
uACR (mg/g), extracted from the electronic medical record; log-transformed and reported as ratios of geometric means. |
Baseline and Week 12
|
Andere uitkomstmaten
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Feasibility: Proportion of Eligible Patients Who Enroll and Complete Follow-up
Tijdsspanne: Enrollment through Week 12 follow-up
|
Proportion of eligible patients who enroll and complete follow-up. |
Enrollment through Week 12 follow-up
|
|
Reach: Demographic Comparability of Enrolled Participants With the Clinic's CKM Population
Tijdsspanne: Enrollment period
|
Demographic comparability between enrolled participants and the clinic's CKM population. |
Enrollment period
|
|
Fidelity: Percentage of CHW Sessions Meeting All Required Elements
Tijdsspanne: Weeks 1-12
|
Percentage of CHW sessions meeting all required elements, assessed through CHW session checklists, direct observation, and periodic audio review. |
Weeks 1-12
|
|
Acceptability: Theoretical Framework of Acceptability (TFA) Survey Score
Tijdsspanne: Week 12
|
Theoretical Framework of Acceptability (TFA) survey completed by intervention participants. |
Week 12
|
|
Adoption: Proportion of RDs, CHWs, and Food Partners Delivering the Program as Intended
Tijdsspanne: Up to 21 months (intervention delivery period)
|
Proportion of participating registered dietitians, CHWs, and food partners delivering the program as intended. |
Up to 21 months (intervention delivery period)
|
|
Incremental Cost per Participant (US Dollars)
Tijdsspanne: 12 weeks
|
Estimated from staff time, session duration, and supply costs, with cost per unit outcome. |
12 weeks
|
Medewerkers en onderzoekers
Sponsor
Sponsor
Medewerkers
Medewerkers
Onderzoekers
Onderzoekers
- Hoofdonderzoeker: Janet Diaz Martinez, Florida International University
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Studie start
Primaire voltooiing (Geschat)
Primaire voltooiing
Studie voltooiing (Geschat)
Studie voltooiing
Studieregistratiedata
Eerst ingediend
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Eerst geplaatst
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update geplaatst
Laatste update ingediend die voldeed aan QC-criteria
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Endocriene systeemziekten
- Vaatziekten
- Hart-en vaatziekten
- Pathologische processen
- Mannelijke urogenitale ziekten
- Nier Ziekten
- Urologische ziekten
- Vrouwelijke urogenitale ziekten
- Vrouwelijke urogenitale ziekten en zwangerschapscomplicaties
- Hartziekten
- Chronische ziekte
- Ziekte attributen
- Metabole ziekten
- Glucosemetabolismestoornissen
- Suikerziekte
- Nierinsufficiëntie
- Hartfalen
- Pathologische aandoeningen, tekenen en symptomen
- Voedings- en stofwisselingsziekten
- Hypertensie
- Diabetes mellitus, type 2
- Nierinsufficiëntie, chronisch
- Cardio-renaal syndroom
Andere studie-ID-nummers
Andere studie-ID-nummers
- IRB-26-0430
- 2027-68015-47755 (Ander subsidie-/financieringsnummer: USDA National Institute of Food and Agriculture)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Following publication of primary findings, de-identified datasets, data dictionaries, and codebooks will be made available through FIU's secure repository. Shared files will exclude personally identifiable information and contain only derived variables.
IPD-tijdsbestek voor delen
Following publication of primary findings; data will remain available for at least five years after project completion or publication of final results, whichever occurs later.
IPD-toegangscriteria voor delen
De-identified datasets, data dictionaries, codebooks, and analytic code will be available to researchers through FIU's institutional repository and, where applicable, the USDA Ag Data Commons, under FIU's Open Data Policy for research and educational re-use with attribution. Shared files will exclude personally identifiable information and contain only derived variables. Requests for restricted materials, such as qualitative transcripts, will require a data-use agreement and ethics approval.
IPD delen Ondersteunend informatietype
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .